Epkinly (epcoritamab-bysp) is a brand-name drug prescribed for diffuse large B-cell lymphoma (DLBCL) in some adults. It’s given as a subcutaneous injection by a healthcare professional. The dosage ...
Kalbitor (ecallantide) is a brand-name drug that’s prescribed for hereditary angioedema attacks in adults and some children. Kalbitor comes as a liquid that’s given as a subcutaneous injection by a ...
The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of lecanemab (Leqembi Iqlik) for weekly maintenance dosing to treat Alzheimer’s ...
Panelists discuss how the IMscin001 trial findings established subcutaneous atezolizumab noninferiority with comparable efficacy and safety to intravenous (IV) formulation while highlighting ...
The FDA has approved a subcutaneous formulation of lecanemab (Leqembi Iqlik, Eisai/Biogen) for maintenance dosing in patients with Alzheimer’s disease (AD) with mild cognitive impairment (MCI) or mild ...
STOCKHOLM, Aug. 29, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA-B) partner Eisai announced today the U.S. Food and Drug Administration (FDA) has approved the Biologics License ...
The first immune checkpoint inhibitor that can be administered via subcutaneous injection in just 1 to 2 minutes has emerged. Alteogen announced on the 20th that its partner Merck (MSD) in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback